Phocas Financial Corp’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Sell
37,297
-1,973
-5% -$82.7K 0.3% 113
2026
Q1
$1.26M Sell
39,270
-10,961
-22% -$406K 0.2% 123
2025
Q4
$2.11M Sell
50,231
-122
-0.2% -$4.92K 0.28% 110
2025
Q3
$1.73M Buy
50,353
+1,028
+2% +$29.5K 0.22% 115
2025
Q2
$1.33M Buy
49,325
+7
+0% +$203 0.19% 110
2025
Q1
$1.46M Sell
49,318
-2,791
-5% -$106K 0.22% 112
2024
Q4
$2.06M Buy
+52,109
New +$1.97M 0.28% 110

Other funds holding VCYT

Phocas Financial Corp's VCYT Position: Q2 2026 in Review

Phocas Financial Corp reduced its Veracyte (VCYT) stake by 5% in Q2 2026, selling an estimated $82.7K and leaving 37,297 shares worth $2.19M. The position accounts for 0.3% of the portfolio, ranked #113.

Phocas Financial Corp first reported a position in VCYT in Q4 2024 and has held it in 7 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Phocas Financial Corp held 37,297 shares of Veracyte worth $2.19M as of Q2 2026.
  • Phocas Financial Corp sold 1,973 Veracyte shares in Q2 2026, an estimated $82.7K.
  • Veracyte made up 0.3% of Phocas Financial Corp's portfolio in Q2 2026, its #113 holding.
  • Phocas Financial Corp first reported a position in Veracyte in Q4 2024 and has held it in 7 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Phocas Financial Corp's 13F filing for Q2 2026, filed 31 Jul 2026.